Xtl Biopharmaceuticals XTLB
NASDAQ XTLB
$1.96 0.00 (-0.01%)
As of: Oct 19, 2026 · 12:25 PM EDT

Xtl Biopharmaceuticals (XTLB) Gross Profit (2011 - 2024)

Updated

Xtl Biopharmaceuticals' Gross Profit was -$43,000 in the quarter ended Dec 31, 2024.

Analysis

Xtl Biopharmaceuticals (XTLB) Gross Profit (2011 - 2024) Analysis & Trends

For the year ended Dec 31, 2024, Gross Profit at Xtl Biopharmaceuticals came in at $3,000.

  • The figure for the quarter ended Dec 31, 2024 marks the highest quarterly Gross Profit in data going back to the quarter ended Jun 30, 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.45 Bn 1,115.03 Bn 19.71 Bn
2 Johnson & Johnson 622.49 Bn 541.02 Bn 17.26 Bn
3 AbbVie 509.47 Bn 482.58 Bn 12.70 Bn
4 Merck 365.43 Bn 319.80 Bn 12.21 Bn
5 Novartis Ag 297.34 Bn 261.33 Bn 11.24 Bn
6 Astrazeneca 261.32 Bn 235.01 Bn 12.86 Bn
7 Amgen 235.29 Bn 190.69 Bn 7.24 Bn
8 Gilead Sciences 193.80 Bn 167.99 Bn 6.22 Bn
9 Pfizer 171.68 Bn 118.33 Bn 10.94 Bn
10 Xtl Biopharmaceuticals 18.55 Mn 15.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -43,000.00
Sep 30, 2014 166,000.00
Jun 30, 2014 267,000.00
Mar 31, 2014 430,000.00
Dec 31, 2013 537,000.00
Sep 30, 2013 293,000.00
Jun 30, 2013 324,000.00
Mar 31, 2013 474,000.00
Dec 31, 2012 371,000.00
Sep 30, 2012 187,000.00
Jun 30, 2012 358,000.00
Mar 31, 2012 395,000.00
Dec 31, 2011 576,000.00
Sep 30, 2011 359,000.00
Jun 30, 2011 548,000.00
API Access

Xtl Biopharmaceuticals Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=XTLB&period=max&api_key=YOUR_API_KEY